Amphastar Pharmaceuticals Long Term Debt 2012-2024 | AMPH

Amphastar Pharmaceuticals long term debt from 2012 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Amphastar Pharmaceuticals Annual Long Term Debt
(Millions of US $)
2023 $590
2022 $73
2021 $75
2020 $34
2019 $39
2018 $32
2017 $41
2016 $32
2015 $30
2014 $36
2013 $10
2012 $16
2011 $
2009 $
Amphastar Pharmaceuticals Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $596
2024-06-30 $587
2024-03-31 $594
2023-12-31 $590
2023-09-30 $638
2023-06-30 $488
2023-03-31 $73
2022-12-31 $73
2022-09-30 $74
2022-06-30 $74
2022-03-31 $74
2021-12-31 $75
2021-09-30 $76
2021-06-30 $30
2021-03-31 $32
2020-12-31 $34
2020-09-30 $33
2020-06-30 $35
2020-03-31 $36
2019-12-31 $39
2019-09-30 $38
2019-06-30 $40
2019-03-31 $31
2018-12-31 $32
2018-09-30 $33
2018-06-30 $34
2018-03-31 $40
2017-12-31 $41
2017-09-30 $42
2017-06-30 $40
2017-03-31 $31
2016-12-31 $32
2016-09-30 $34
2016-06-30 $32
2016-03-31 $29
2015-12-31 $30
2015-09-30 $31
2015-06-30 $35
2015-03-31 $36
2014-12-31 $36
2014-09-30 $41
2014-06-30 $43
2014-03-31 $10
2013-12-31 $10
2013-09-30
2013-06-30
2013-03-31
2012-12-31 $16
2012-09-30
2012-06-30
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.097B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00